SMAD7 and MGMT genotype variants and cancer incidence in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk Study

Cancer Epidemiology

Volumn 35, Issue 4, 2011, Pages 369-374

  Loh, Yet Hua ^a   Mitrou, Panagiota N ^a,b   Wood, Angela ^a   Luben, Robert N ^a   McTaggart, Alison ^a   Khaw, Kay Tee ^a   Rodwell, Sheila A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b WORLD CANCER RESEARCH FUND INTERNATIONAL   (United Kingdom)

Author keywords

Cancer; EPIC Norfolk study; Genotype; MGMT; SMAD7; Variants

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; SMAD7 PROTEIN;

ADULT; AGE; AGED; ALLELE; ARTICLE; BODY MASS; BREAST CANCER; CANCER INCIDENCE; CIGARETTE SMOKING; COHORT ANALYSIS; COLORECTAL CANCER; EXPLORATORY RESEARCH; FEMALE; FOLLOW UP; GENDER; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; COHORT STUDIES; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GREAT BRITAIN; HUMANS; INCIDENCE; MALE; MIDDLE AGED; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; SMAD7 PROTEIN; TUMOR SUPPRESSOR PROTEINS;

EID: 79960587338     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2010.09.011     Document Type: Article

References (30)

1. Broderick P., Carvajal-Carmona L., Pittman A.M., Webb E., Howarth K., Rowan A., et al. A genome-wide association study shows that common alleles of SMAD7 influence colorectal cancer risk. Nat Genet 2007, 39(11):1315-1317.
2. Vineis P., Manuguerra M., Kavvoura F.K., Guarrera S., Allione A., Rosa F., et al. A field synopsis on low-penetrance variants in DNA repair genes and cancer susceptibility. J Natl Cancer Inst 2009, 101(1):24-36.
3. Derynck R., Akhurst R.J., Balmain A. TGF-beta signaling in tumor suppression and cancer progression. Nat Genet 2001, 29(2):117-129.
4. Xu Y., Pasche B. TGF-beta signaling alterations and susceptibility to colorectal cancer. Hum Mol Genet 2007, 16(Spec. No. 1):R14-R20.
5. Akhurst R.J. TGF beta signaling in health and disease. Nat Genet 2004, 36(8):790-792.
6. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998, 67:753-791.
7. Zhu H.J., Burgess A.W. Regulation of transforming growth factor-beta signaling. Mol Cell Biol Res Commun 2001, 4(6):321-330.
8. Levy L., Hill C.S. Alterations in components of the TGF-beta superfamily signaling pathways in human cancer. Cytokine Growth Factor Rev 2006, 17(1-2):41-58.
9. Korchynskyi O., Landstrom M., Stoika R., Funa K., Heldin C.H., ten D.P., et al. Expression of Smad proteins in human colorectal cancer. Int J Cancer 1999, 82(2):197-202.
10. Yan X., Liu Z., Chen Y. Regulation of TGF-beta signaling by Smad7. Acta Biochim Biophys Sin (Shanghai) 2009, 41(4):263-272.
11. Tenesa A., Farrington S.M., Prendergast J.G., Porteous M.E., Walker M., Haq N., et al. Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet 2008, 40(5):631-637.
12. Curtin K., Lin W.Y., George R., Katory M., Shorto J., Cannon-Albright L.A., et al. Meta association of colorectal cancer confirms risk alleles at 8q24 and 18q21. Cancer Epidemiol Biomarkers Prev 2009, 18(2):616-621.
13. Thompson C.L., Plummer S.J., Acheson L.S., Tucker T.C., Casey G., Li L. Association of common genetic variants in SMAD7 and risk of colon cancer. Carcinogenesis 2009, 30(6):982-986.
14. Mirvish S.S. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution to cancer of known exposures to NOC. Cancer Lett 1995, 93(1):17-48.
15. Kaur T.B., Travaline J.M., Gaughan J.P., Richie J.P., Stellman S.D., Lazarus P. Role of polymorphisms in codons 143 and 160 of the O6-alkylguanine DNA alkyltransferase gene in lung cancer risk. Cancer Epidemiol Biomarkers Prev 2000, 9(3):339-342.
16. Shen J., Terry M.B., Gammon M.D., Gaudet M.M., Teitelbaum S.L., Eng S.M., et al. MGMT genotype modulates the associations between cigarette smoking, dietary antioxidants and breast cancer risk. Carcinogenesis 2005, 26(12):2131-2137.
17. Tranah G.J., Bugni J., Giovannucci E., Ma J., Fuchs C., Hines L., et al. O6-methylguanine-DNA methyltransferase Leu84Phe and Ile143Val polymorphisms and risk of colorectal cancer in the Nurses' Health Study and Physicians' Health Study (United States). Cancer Causes Control 2006, 17(5):721-731.
18. Neasham D., Gallo V., Guarrera S., Dunning A., Overvad K., Tjonneland A., et al. Double-strand break DNA repair genotype predictive of later mortality and cancer incidence in a cohort of non-smokers. DNA Repair (Amst) 2009, 8(1):60-71.
19. Sandhu M.S., Waterworth D.M., Debenham S.L., Wheeler E., Papadakis K., Zhao J.H., et al. LDL-cholesterol concentrations: a genome-wide association study. Lancet 2008, 371(9611):483-491.
20. Day N., Oakes S., Luben R., Khaw K.T., Bingham S., Welch A., et al. EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer. Br J Cancer 1999, 80(Suppl. 1):95-103.
21. Riboli E. Nutrition and cancer: background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC). Ann Oncol 1992, 3(10):783-791.
22. Bingham S.A., Welch A.A., McTaggart A., Mulligan A.A., Runswick S.A., Luben R., et al. Nutritional methods in the European Prospective Investigation of Cancer in Norfolk. Public Health Nutr 2001, 4(3):847-858.
23. Welch A.A., McTaggart A., Mulligan A.A., Luben R., Walker N., Khaw K.T., et al. DINER (Data Into Nutrients for Epidemiological Research) - a new data-entry program for nutritional analysis in the EPIC-Norfolk cohort and the 7-day diary method. Public Health Nutr 2001, 4(6):1253-1265.
24. Katoh Y., Katoh M. Hedgehog signaling pathway and gastrointestinal stem cell signaling network. Int J Mol Med 2006, 18(6):1019-1023. [review].
25. Pittman A.M., Naranjo S., Webb E., Broderick P., Lips E.H., van W.T., et al. The colorectal cancer risk at 18q21 is caused by a novel variant altering SMAD7 expression. Genome Res 2009, 19(6):987-993.
26. Gibson L., Johnson N., Fraser A., dos S.S.I., Houlston R., Peto J., et al. No breast cancer association for transforming growth factor-beta pathway colorectal cancer single nucleotide polymorphisms. Cancer Epidemiol Biomarkers Prev 2009, 18(6):1934-1936.
27. Ten D.P., Hill C.S. New insights into TGF-beta-Smad signalling. Trends Biochem Sci 2004, 29(5):265-273.
28. Hussain S.P., Harris C.C. Inflammation and cancer: an ancient link with novel potentials. Int J Cancer 2007, 121(11):2373-2380.
29. Schetter A.J., Heegaard N.H., Harris C.C. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. Carcinogenesis 2010, 31(1):37-49.
30. Tenesa A., Dunlop M.G. New insights into the aetiology of colorectal cancer from genome-wide association studies. Nat Rev Genet 2009, 10(6):353-358.